Sava Infond’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.21M Buy
46,020
+19,910
+76% +$3.51M 0.44% 45
2026
Q1
$4.69M Sell
26,110
-10,400
-28% -$1.78M 0.67% 33
2025
Q4
$5.16M Sell
36,510
-17,900
-33% -$2.03M 0.7% 26
2025
Q3
$4.41M Buy
54,410
+14,500
+36% +$1.12M 0.63% 33
2025
Q2
$2.5M Buy
39,910
+16,900
+73% +$999K 0.39% 44
2025
Q1
$1.66M Sell
23,010
-4,000
-15% -$326K 0.32% 69
2024
Q4
$2.33M Buy
+27,010
New +$2.69M 0.41% 48

Other funds holding ALB

Sava Infond's ALB Position: Q2 2026 in Review

Sava Infond increased its Albemarle (ALB) stake by 76% in Q2 2026, buying an estimated $3.51M and bringing the position to 46,020 shares worth $6.21M. The position accounts for 0.44% of the portfolio, ranked #45.

Sava Infond first reported a position in ALB in Q4 2024 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Sava Infond held 46,020 shares of Albemarle worth $6.21M as of Q2 2026.
  • Sava Infond bought 19,910 Albemarle shares in Q2 2026, an estimated $3.51M.
  • Albemarle made up 0.44% of Sava Infond's portfolio in Q2 2026, its #45 holding.
  • Sava Infond first reported a position in Albemarle in Q4 2024 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.